2 assets in Vascular Neoplasm

Therapeutic assets addressing Vascular Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Pembrolizumab Vascular Neoplasm	M.D. Anderson Cancer Center	P2	CCC (53)
Atezolizumab Vascular Neoplasm	Third Affiliated Hospital, Sun Yat-Sen University	N/A	D (30)